This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
PANW Deepens Ties With Google: Will This Enhance Prisma AIRS Adoption?
by Om Jaiswal
Palo Alto Networks deepens its Google Cloud partnership by embedding Prisma AIRS into AI services, aiming to boost adoption as AI workloads scale.
CrowdStrike (CRWD) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to CrowdStrike (CRWD). This makes it worthwhile to examine what the stock has in store.
Can Cortex XSIAM Become Palo Alto Networks' Next Major Growth Engine?
by Om Jaiswal
PANW's Cortex XSIAM is landing bigger deals and high-spending customers, signaling it could emerge as a key growth driver.
Can Falcon Flex Become CrowdStrike's Most Important Growth Engine?
by Om Jaiswal
CRWD's Falcon Flex ARR surges past $1.3B, as faster module adoption and expanding deals turn it into a core growth driver.
FTNT's Premium Valuation Raises Concerns: Buy, Sell or Hold the Stock?
by Vasundhara Sawalka
Fortinet's premium valuation, slowing service revenues and cautious guidance offset strong margins and SASE growth, prompting investors to consider a hold stance.
PANW vs. CRWD: Which Cybersecurity Stock Has an Edge Right Now?
by Om Jaiswal
CrowdStrike's Falcon Flex surge and faster revenue growth give it the edge over Palo Alto Networks in the battle for cybersecurity dominance.
CrowdStrike Stock Rises 51% YTD: Time to Hold or Book Profits?
by Om Jaiswal
CRWD's 51% YTD rally, powered by Falcon Flex adoption and soaring Next-Gen SIEM demand, raises the question of whether to hold or lock in gains.
Can Next-Generation SIEM Become CrowdStrike's Biggest Growth Engine?
by Om Jaiswal
CRWD's Next-Generation SIEM accelerates with record ARR, major wins and AWS integration, strengthening its role as a key platform growth driver.
Investors Heavily Search CrowdStrike (CRWD): Here is What You Need to Know
by Zacks Equity Research
CrowdStrike (CRWD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Wall Street Bulls Look Optimistic About CrowdStrike (CRWD): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for CrowdStrike (CRWD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?